Status:
COMPLETED
Standardized Infant NeuroDevelopmental Assessment (SINDA) in 0-24 Months Age in Turkey
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Infant, Premature, Diseases
Motor Development
Eligibility:
All Genders
1-24 years
Brief Summary
This study aims to assess Turkish validity and reliability of Standardized Infant Neurodevelopmental Assessment and to spread its use for evaluation in early rehabilitation in our country.
Detailed Description
There are developments in the field of diagnosing children with a high risk of developmental disorders such as cerebral palsy (CP), mental problems and autism spectrum disorder in infancy. In particul...
Eligibility Criteria
Inclusion
- at-risk infants
- discharged from neonatal intensive care unit;
- age between 0 - 24 months old (corrected age for premature infants);
- having a family acceptance for the participation
Exclusion
- having congenital anomalies,
- musculoskeletal disorders,
- cyanotic congenital heart disease and
- mechanical dependency
Key Trial Info
Start Date :
July 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04889027
Start Date
July 17 2020
End Date
July 1 2021
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nilay Çömük Balci
Samsun, Atakum, Turkey (Türkiye), 55139